Редактирование: BMP7 (раздел)

==Publications==

{{medline-entry
|title=[[GREM1]] inhibits osteogenic differentiation, senescence and BMP transcription of adipose-derived stem cells.
|pubmed-url=https://pubmed.ncbi.nlm.nih.gov/32151168
|abstract=: Adipose-derived stem cells (ADSCs) are ideal for cell-based therapies to support bone regeneration. It is vital to understand the critical genes and molecular mechanisms involved in the functional regulation of ADSCs for enhancing bone regeneration. In the present study, we investigated the Gremlin 1 ([[GREM1]]) effect on ADSCs osteogenic differentiation and senescence. : The [i]in vitro[/i] ADSCs osteogenic differentiation potential was evaluated by determining alkaline phosphatase (ALP) activity, mineralization ability, and the expression of osteogenic markers. Cell senescence is determined by SA-β-gal staining, telomerase assay, and the expression of aging markers. : [[GREM1]] overexpression in ADSCs reduced ALP activity and mineralization, inhibited the expression of osteogenic related genes [i]OCN, OPN, [[DSPP]], [[DMP1]][/i], and [i]BSP[/i], and key transcription factors, [i]RUNX2[/i] and [i]OSX[/i]. [[GREM1]] knockdown in ADSCs enhanced ALP activity and mineralization, promoted the expression of [i]OCN, OPN, [[DSPP]], [[DMP1]], BSP, RUNX2[/i], and [i]OSX[/i]. [[GREM1]] overexpression in ADSCs reduced the percent SA-β-Gal positive cells, [i]P16[/i] and [i]P53[/i] expressions, and increased telomerase activity. [[GREM1]] knockdown in ADSCs increased the percentage of SA-β-Gal positive cells, [i]P16[/i] and [i]P53[/i] expressions, and reduced telomerase activity. Furthermore, [[GREM1]] reduced the mRNA expression levels of [[BMP2]], [[BMP6]], and [[BMP7]]. : In summary, our findings suggested that [[GREM1]] inhibited ADSCs senescence and osteogenic differentiation and antagonized BMP transcription.

|keywords=* BMP
* GREM1
* adipose-derived stem cells (ADSCs)
* osteogenic differentiation
* senescence
|full-text-url=https://sci-hub.do/10.1080/03008207.2020.1736054
}}
{{medline-entry
|title=Downregulation of miR-542-3p promotes osteogenic transition of vascular smooth muscle cells in the aging rat by targeting [[BMP7]].
|pubmed-url=https://pubmed.ncbi.nlm.nih.gov/31829291
|abstract=Aging is believed to have a close association with cardiovascular diseases, resulting in various pathological alterations in blood vessels, including vascular cell phenotypic shifts. In aging vessels, the microRNA(miRNA)-mediated mechanism regulating the vascular smooth muscle cell (VSMC) phenotype remains unclarified. MiRNA microarray was used to compare the expressions of miRNAs in VSMCs from old rats (oVSMCs) and young rats (yVSMCs). Quantitative reverse transcription real-time PCR (qRT-PCR) and small RNA transfection were used to explore the miR-542-3p expression in oVSMCs and yVSMCs in vitro. Calcification induction of yVSMCs was conducted by the treatment of β-glycerophosphate (β-GP). Alizarin red staining was used to detect calcium deposition. Western blot and qRT-PCR were used to investigate the expression of the smooth muscle markers, smooth muscle 22α (SM22α) and calponin, and the osteogenic markers, osteopontin (OPN), and runt-related transcription factor 2 (Runx2). Lentivirus was used to overexpress miR-542-3p and bone morphogenetic protein 7 ([[BMP7]]) in yVMSCs. Luciferase reporter assay was conducted to identify the target of miR-542-3p. Compared with yVSMCs, 28 downregulated and 34 upregulated miRNAs were identified in oVSMCs. It was confirmed by qRT-PCR that oVSMC expressed four times lower miR-542-3p than yVSMCs. Overexpressing miR-542-3p in yVSMCs suppressed the osteogenic differentiation induced by β-GP. Moreover, miR-542-3p targets [[BMP7]] and overexpressing [[BMP7]] in miR-542-3p-expressing yVSMCs reverses miR-542-3p's inhibition of osteogenic differentiation. miR-542-3p regulates osteogenic differentiation of VSMCs through targeting [[BMP7]], suggesting that the downregulation of miR-542-3p in oVSMCs plays a crucial role in osteogenic transition in the aging rat.
|mesh-terms=* Aging
* Animals
* Base Sequence
* Bone Morphogenetic Protein 7
* Down-Regulation
* Glycerophosphates
* MicroRNAs
* Models, Biological
* Muscle, Smooth, Vascular
* Myocytes, Smooth Muscle
* Osteogenesis
* Rats
|keywords=* Aging
* Mir-542-3p
* Osteogenic differentiation
* Vascular smooth muscle cells
|full-text-url=https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6907335
}}
{{medline-entry
|title=TGF-beta receptor mediated telomerase inhibition, telomere shortening and breast cancer cell senescence.
|pubmed-url=https://pubmed.ncbi.nlm.nih.gov/27696331
|abstract=Human telomerase reverse transcriptase (hTERT) plays a central role in telomere lengthening for continuous cell proliferation, but it remains unclear how extracellular cues regulate telomerase lengthening of telomeres. Here we report that the cytokine bone morphogenetic protein-7 ([[BMP7]]) induces the hTERT gene repression in a BMPRII receptor- and Smad3-dependent manner in human breast cancer cells. Chonic exposure of human breast cancer cells to [[BMP7]] results in short telomeres, cell senescence and apoptosis. Mutation of the BMPRII receptor, but not TGFbRII, ACTRIIA or ACTRIIB receptor, inhibits [[BMP7]]-induced repression of the hTERT gene promoter activity, leading to increased telomerase activity, lengthened telomeres and continued cell proliferation. Expression of hTERT prevents [[BMP7]]-induced breast cancer cell senescence and apoptosis. Thus, our data suggest that [[BMP7]] induces breast cancer cell aging by a mechanism involving BMPRII receptor- and Smad3-mediated repression of the hTERT gene.
|mesh-terms=* Actin-Related Protein 2
* Activin Receptors, Type II
* Bone Morphogenetic Protein 7
* Bone Morphogenetic Protein Receptors, Type II
* Breast Neoplasms
* Cellular Senescence
* Female
* HeLa Cells
* Humans
* MCF-7 Cells
* Neoplasm Proteins
* Protein-Serine-Threonine Kinases
* Receptor, Transforming Growth Factor-beta Type II
* Receptors, Transforming Growth Factor beta
* Smad3 Protein
* Telomerase
* Telomere Homeostasis
|keywords=* BMPRII
* TGFbeta
* breast cancer cells
* hTERT
* senescence
* telomerase
* telomeres
|full-text-url=https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5233610
}}
{{medline-entry
|title=Effects of Usag-1 and Bmp7 deficiencies on murine tooth morphogenesis.
|pubmed-url=https://pubmed.ncbi.nlm.nih.gov/27178071
|abstract=Wnt5a and Mrfzb1 genes are involved in the regulation of tooth size, and their expression levels are similar to that of Bmp7 during morphogenesis, including during the cap and early bell stages of tooth formation. We previously reported that Usag-1-deficient mice form supernumerary maxillary incisors. Thus, we hypothesized that [[BMP7]] and USAG-1 signaling molecules may play important roles in tooth morphogenesis. In this study, we established double genetically modified mice to examine the in vivo inter-relationships between Bmp7 and Usag-1. We measured the volume and cross-sectional areas of the mandibular incisors using micro-computed tomography (micro-CT) in adult Bmp7- and Usag-1-LacZ knock-in mice and their [[F2]] generation upon interbreeding. The mandibular incisors of adult Bmp7 /- mice were significantly larger than those of wild-type (WT) mice. The mandibular incisors of adult Usag-1-/- mice were the largest of all genotypes examined. In the [[F2]] generation, the effects of these genes were additive; Bmp7 /- was most strongly associated with the increase in tooth size using generalized linear models, and the total area of mandibular supernumerary incisors of Usag-1-/-Bmp7 /- mice was significantly larger than that of Usag-1-/-Bmp7  /  mice. At embryonic day 15 (E15), BrdU assays demonstrated that the labeling index of Bmp7 /- embryos was significantly higher than that of WT embryos in the cervical loop. Additionally, the labeling index of Usag-1-/- embryos was significantly the highest of all genotypes examined in dental papilla. Bmp7 heterozygous mice exhibited significantly increased tooth sizes, suggesting that tooth size was controlled by specific gene expression. Our findings may be useful in applications of regenerative medicine and dentistry.
|mesh-terms=* Adaptor Proteins, Signal Transducing
* Aging
* Animals
* Apoptosis
* Bone Morphogenetic Protein 7
* Bone Morphogenetic Proteins
* Bromodeoxyuridine
* Cell Proliferation
* Crosses, Genetic
* Embryo, Mammalian
* Female
* Gene Expression Regulation, Developmental
* Gene Knock-In Techniques
* In Situ Nick-End Labeling
* Incisor
* Linear Models
* Male
* Mandible
* Mice, Inbred C57BL
* Molar
* Morphogenesis
* Organ Size
* Phenotype
* Staining and Labeling
* Tooth
* X-Ray Microtomography
* beta-Galactosidase
|keywords=* Bmp7
* Mouse model
* Tooth morphogenesis
* Tooth size
* Tooth volume
* Usag-1
|full-text-url=https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4866418
}}
{{medline-entry
|title=Conditional deletion of [[BMP7]] from the limb skeleton does not affect bone formation or fracture repair.
|pubmed-url=https://pubmed.ncbi.nlm.nih.gov/19780203
|abstract=While the osteoinductive activity of recombinant bone morphogenetic protein 7 ([[BMP7]]) is well established, evaluation of the role of endogenous [[BMP7]] in bone formation and fracture healing has been hampered by perinatal lethality in [[BMP7]] knockout mice. Here we employ conditional deletion of [[BMP7]] from the embryonic limb prior to the onset of skeletogenesis to create limb bones lacking [[BMP7]]. We find that the absence of locally produced [[BMP7]] has no effect on postnatal limb growth, articular cartilage formation, maintenance of bone mass, or fracture healing. Our data suggest that other BMPs present in adult bone are sufficient to compensate for the absence of [[BMP7]].
|mesh-terms=* Aging
* Animals
* Animals, Genetically Modified
* Animals, Newborn
* Bone Morphogenetic Protein 4
* Bone Morphogenetic Protein 7
* Bone and Bones
* Calcification, Physiologic
* Cartilage, Articular
* Embryo, Mammalian
* Embryonic Development
* Extremities
* Femoral Fractures
* Fracture Healing
* Gene Deletion
* Homeostasis
* Mice
* Mice, Knockout
* Osteogenesis

|full-text-url=https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2862367
}}